Vir Biotechnology (VIR) Asset Utilization Ratio (2019 - 2026)

Vir Biotechnology has disclosed Asset Utilization Ratio across 8 years of filings, most recently posting 0.06 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.06, up 319.29% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.06 (up 319.29% YoY), and the FY2025 annual result was 0.06, up 27.63% from the prior year.
• Asset Utilization Ratio came in at 0.06 for Q1 2026 at Vir Biotechnology, down from 0.07 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.96 in Q1 2022 to a low of 0.02 in Q2 2025.
• The 5-year median for Asset Utilization Ratio is 0.06 (2023), against an average of 0.24.
• Across the five-year window, Asset Utilization Ratio soared 1909.12% in 2022 and sank 94.02% in 2023, its largest moves.
• Vir Biotechnology's Asset Utilization Ratio stood at 0.62 in 2022, then tumbled by 92.96% to 0.04 in 2023, then grew by 10.39% to 0.05 in 2024, then soared by 41.26% to 0.07 in 2025, then declined by 4.67% to 0.06 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.06 (Q1 2026), 0.07 (Q4 2025), and 0.02 (Q3 2025), per Business Quant data.